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1. Introduction
   Malaria is the worldÊs most important parasitic infectious disease 
ranking among the major health and developmental challenges. 
Malaria is caused by the protozoan Plasmodium transmitted by the 
female Anopheles mosquitoes. Despite years of continual efforts, the 
disease remains one of the major causes of morbidity and mortality 
affecting third-world countries and still a threat to over 2 billion 
people, representing approximately 40% of the worldÊs population 
in about 100 countries. Best estimates currently describe the annual 
global burden of malaria as 300-500 million cases and 1-2 million 
deaths. Over 90% of the disease burden is in sub-Saharan Africa[1]. 
AIDS due to infection with HIV is a very serious contemporary 
pandemic.  Millions of people are infected with high fatal rate 
each year. World statistics shows the estimated cases of individuals 
infected with HIV in 2010 as follows: people living with HIV/AID 
34 million, new infection 2.7 million and death cases 1.8 million[2]. 
Malaria and HIV/AIDS have overlapping geographical distribution. 
Together, the two diseases account for 4 million deaths a year 
worldwide[3]. Malaria disproportionately affects young children 
and pregnant women and HIV/AIDS affects mostly adolescents and 
young adults. Since 2009, the CDC has included malaria in the list 
of AIDS-related opportunistic infections; even though malaria is not 
among the leading causes of death in HIV-infected patients, it has 
been identified as the third most important source of HIV-related 
morbidity in Africa. The major burden of malaria and HIV occurs 
in Sub-Saharan Africa, Southeast Asia, Latin America and the 
Caribbean. However, the prevalence of malaria and HIV as well as 
the extent of geographical overlap varies widely within each region. 
The prevalence of malaria-HIV co-infection reported from Africa 
is approximately 10%[1]. There has been, however, no information 
on the prevalence of malaria-HIV co-infection in Thailand. In 
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areas with stable malaria transmission, HIV increases risk of 
malaria infection and clinical malaria especially in individuals with 
advanced immuno-suppression and in areas with unstable malaria 
transmission; HIV-infected individuals are at increased risk for 
severe malaria and death[1]. Interactions between antimalarial and 
antiretroviral drugs in patients with co-infection of both diseases, 
either pharmacodynamically or pharmacokinetically could also 
have profound public health consequences. The aim of the study 
was to preliminarily investigate the prevalence of HIV co-infection 
in patients with malaria in Mae Sot District, Tak Province of 
Thailand, the area with highest malaria incidence of the country.
2. Materials and methods 
2.1. Study site and patients
   The study was a retrospective study on blood samples collected 
from a total of 256 patients with malaria (all species and severity) 
who attended Mae Tao clinic for migrant workers, Tak Province 
during 2005-2007 (148 samples) and 2010-2012 (108 samples). 
Malaria is a serious imported medical problem in this area with a 
low and stable disease transmission with two seasonal peaks and 
forest-related during May-August and November-January of each 
year. Anopheles minimus and Anopheles dirus are the principal 
vectors. The study was approved by the Ethics Committee of the 
Institute for the Development of Human Research Protection, 
Thailand. Demographic and parasitological data of all patients are 
recorded.
2.2. Malaria diagnosis 
   The diagnosis of malaria was done according to clinical and 
parasitological examination[4]. Finger-pricked blood samples 
(100 μL each) were obtained from all patients on enrolment and 
blood smears were prepared and stained with Giemsa. Thick films 
were screened for 200 oil-immersion fields. Asexual parasites and 
gametocytes were separately counted against 200 white blood 
cells; if the parasite density was too numerous to count on the thick 
film, the number of parasites per 2 000 red blood cells on the thin 
film was counted. 
2.3. HIV diagnosis
   The chemiluminescent microparticle immunoassay was 
performed to detect HIV antigen using 500 μL plasma samples. The 
assay principle combines a two-step sandwich chemiluminescent 
immunoassay to determine the presence of HIV p24 antigen and 
antibodies to HIV-1 in human plasma. A chemiluminescence signal 
is generated and photons are counted. The result was measured in 
relative light unit which was directly proportional to amount of 
HIV-1 p24 antigen present in sample. The result was expressed as 
sample/cut off (S/CO); S/CO value 1 is considered non reactive 
and S/CO value ı1 is considered reactive. It was confirmed by gel 
particle passive agglutination in which antigen-coated particles are 
allowed to react with serum antibodies to form visible clumping[5]. 
A result is regarded as positive reaction to HIV when control 
particles (final dilution 1:16) are not agglutinated and sensitized 
particles (final specimen dilution 1:32 or more) give a definite 
agglutination pattern. 
2.4. Data analysis
   Categorical data are presented as number and proportion (%).
3. Results 
   Results of the present study (Table 1) showed that the majority 
of patients were Burmese (71.6% and 100% of total cases in 2005-
2007 and 2010-2012, respectively). The minority of the cases were 
Karen and Thai (24.3% and 4.1% in 2005-2007, respectively). The 
infection was found in all age groups, but was most common in 
adults aging 15-24 years. The proportion of male was higher than 
female patients during the year 2005-2007 (72.3% vs. 27.7%) but 
was inversed during 2010-2012 (43.5% vs. 56.5%). P. falciparum 
and P. vivax were the two predominant malaria species with the ratio 
of about 1:1 to 1.5:1. Plasmodium malariae is occasionally found 
and Plasmodium ovale is rare. All age groups are affected and nearly 
all the P. falciparum infections are symptomatic. Most of the P. 
falciparum cases were presented with acute uncomplicated signs and 
symptoms with highest parasitemia of asexual parasites/μL blood. 
The prevalence of HIV-malaria co-infected cases in this malaria 
endemic area of the country was 1.35% (2/148 cases, 1 each for P. 
falciparum and P. vivax co-infection) during 2005-2007 to 2.78% 
(3/108 cases, 2 and 1 for P. falciparum and P. vivax co-infection, 
respectively) during 2010-2012.
Table 1 
Demographics, prevalence of malaria infection and malaria-HIV co-
infection in the population in malaria endemic area of Mae Sot District, Tak 
province, Thailand.
Characteristics
2005-2007 
(n = 148)
2010-2012 
(n = 108)
n (%) n (%)
Sex Male 107 72.300 47   43.50
Female 41 27.700 61   56.50
Age (years) 15-19 44 29.700
20-24 35 23.700
25-29 21 14.200
30-34 13   8.800 No data No data
35-39 11   7.400
40-44 12   8.100
45-49 6   4.000
50-54 2   1.400
55-60 4   2.700
Ethnic Burmese 106 71.600 108 100.00
Karen 36 24.300 0     0.00
Thai 6   4.100 0     0.00
Malaria 
species
P. falciparum 87 58.800 55   50.90
P. vivax 52 35.100 53   49.10
Plasmodium malariae 1   0.700 - -
P. falciparum/P. vivax mixed 8   5.400 - -
Parasite 
density (/μL)
None 1   0.700 1     0.90
< 1 000 6   4.100 6     5.60
1 000 - < 10 000 34 23.000 75   69.40
ı10 000 107 72.300 26   24.10
HIV co-infection 2   1.350 3     2.78
with P. falciparum 1   0.675 2     1.85
with P. vivax 1   0.675 1     0.93
4. Discussion
   Mae Sot District on the western border of Thailand has been 
continuously reported as the province with highest malaria incidence 
of the country since 1996[6]. Results obtained from the two 
investigation periods suggested the increasing trend of HIV-malaria 
co-infected cases in this malaria endemic area of the country from 
1.35% during 2005-2007 to 2.78% during 2010-2012. This was 
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considered relatively low comparing with that reported in Africans[1]
and Indians[7], of which co-infection rates of approximately 10% 
and 9.8% respectively, were reported. Unfortunately, most of the 
cases included in the present study were Burmese population and 
thus actual information on the prevalence of co-infection in the Thai 
population could not be estimated. The study in a larger numbers of 
malaria patients in different endemic areas throughout the country 
is underway.
   HIV is a retrovirus that belongs to the genus Lentivirus. There 
are two major HIV subtypes, i.e., type 1 (HIV-1) and type 2 (HIV-2). 
HIV-1 is most widespread in the world, while HIV-2 was mostly 
found in West Africa[8,9]. The major concern of malaria and HIV 
co-infection is that both may synergetically affect the pathogenesis 
of each other. In addition, either infection might also influence 
the clinical course of the other. HIV infection has been reported 
to increase the parasitemia in patients which will in turn facilitate 
the transmission of malaria infection[10]. Several in vitro and in 
vivo studies demonstrated that P. falciparum co-infection rapidly 
enhanced the expression of HIV proteins, mRNA and p24, as 
well as stimulation of interferon alpha, interferon gamma and 
macrophage inflammatory protein 1 alpha production. The later led 
to up-regulation of CD4 expression that could be the driving factor 
in the HIV replication[11,12]. The observation was later confirmed 
by the following cohort studies in Northern Uganda which showed 
that HIV-1 RNA concentration was nearly doubled from the baseline 
value (96 215 copies per mL) and the cases with only malaria 
infection (168 901 copies per mL)[13]. It is also claimed that HIV-1 
viral burden is tenfold higher in patients with P. falciparum malaria 
than in controls in Zambian adults[14]. Furthermore, it is argued that 
antimalarial treatment failure may be more common in HIV-infected 
adults with low CD4-cell counts compared to the non-infected 
individuals[15].
   The influence of HIV infection and malaria severity remains 
however, controversial. Based on the results of the present study, 
the association between HIV-malaria co-infection and severity of 
malaria disease could not definitely assess. In a previous study 
in Zambia, cases of severe malaria clearly attributable to malaria 
could not be confirmed in patients co-infected with malaria, 
because several opportunistic infections of AIDS patients could 
have clinical presentations similar to those of severe malaria[15]. 
On the other hand, the prospective studies of severe malaria from 
Mozambique and Zambia both suggested that HIV-infected adults 
have a higher malaria case-fatality rate[15,16]. Moreover, Hochman 
and Kim claimed that HIV infection tends to increase episodes of 
symptomatic malaria and risk of severe or complicated malaria 
including death in both children and adults. These conflicting 
conclusions on the effect of HIV infection on malaria severity could 
be explained by variability in the CD4 lymphocyte counts of the 
patients[17]. A study in Nigerian showed a greater prevalence of 
parasitemia episodes and severity of fever in HIV-infected patients 
with low CD4-cell count[10]. 
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